Role of Smad3 in obiliterative bronchiolitis
Role of Smad3 in obiliterative bronchiolitis
批准号:
8232753
负责人:
ALLAN RAMIREZ
金额:
$11.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-15 至 2012-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Obliterative bronchiolitis (OB), considered to be a manifestation of chronic allograft dysfunction in lung transplant recipients, is an irreversible fibroproliferative process that represents the major barrier to long term survival. Hence, research directed at identifying the factors involved in the development of OB in lung transplant recipients is paramount to finding effective treatment for this otherwise untreatable disease. We have found that Transforming Growth Factor-p (TGFp) via its signal transducer, SmadS, is necessary for the development of OB as well as the myofibroblast transdifferentiation that accompanies OB. Hence, we have focused on the mechanisms regulating TGFp/Smad signaling in OB and have made a number of key observations. First, oxidation of the extracellular cysteine-cystine (Cys/CySS) redox couple induces upregulation and activation of TGFp and SrnadS. Second, SmadS expression and DNA binding in lung fibroblasts, and consequently, myofibroblast transformation, is augmented by aberrant transitional matrix, components, e.g., fibronectin and type I collagen, which are invariably found in the setting of OB. And third, activation of the nuclear transcription factor, peroxisome proliferator-activated receptor-y (PPARy), inhibits TGFpl -induced myofibroblast transdifferentiation by disrupting SmadS-dependent gene transcription. These findings led us to the hypothesis that activation of TGFp1/Smad3 signaling in airway fibroblasts is a critical driver of myofibroblast transdifferentiation in OB that is intensified by the presence of chronic extracellular oxidant stress, aberrant transitional matrices, and defective PPARy signaling. This hypothesis will be tested in fibroblast cultures and in experimental models of OB in three specific aims designed to: 1) examine the mechanisms by which chronic extracellular oxidative stress activates TGFp1/Smad3-dependent signaling events in vitro and in vivo through the Cys/CySS redox couple 2) examine how transitional matrices promote activation of TGFpl /SmadS signaling and myofibroblast transdifferentiation through integrin-dependent signals 3) determine the mechanisms by which PPARy affects the SmadS signaling pathway and the induction of myofibroblast transdifferentiation and matrix expression in experimental OB. These complex issues will be addressed with the assistance of expert advisors and collaborators with the broader objective of unveiling novel targets for therapy.
(End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vitamin D Status in Pulmonary Fibrosis
-
批准号:8189385
-
项目类别:
-
资助金额:$5.49万
-
财政年份:2009
-
负责人:ALLAN RAMIREZ
-
依托单位:
Vitamin D Status in Pulmonary Fibrosis
-
批准号:7713293
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2009
-
负责人:ALLAN RAMIREZ
-
依托单位:
Vitamin D Status in Pulmonary Fibrosis
-
批准号:7837625
-
项目类别:
-
资助金额:$2.27万
-
财政年份:2009
-
负责人:ALLAN RAMIREZ
-
依托单位:
Role of Smad3 in Obliterative Bronchiolitis
-
批准号:7316949
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2007
-
负责人:ALLAN RAMIREZ
-
依托单位:
Role of Smad3 in Obliterative Bronchiolitis
-
批准号:7663229
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2007
-
负责人:ALLAN RAMIREZ
-
依托单位:
Role of Smad3 in obiliterative bronchiolitis
-
批准号:8113175
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2007
-
负责人:ALLAN RAMIREZ
-
依托单位:
Role of Smad3 in Obliterative Bronchiolitis
-
批准号:7485737
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2007
-
负责人:ALLAN RAMIREZ
-
依托单位:
Role of Smad3 in obiliterative bronchiolitis
-
批准号:7902078
-
项目类别:
-
资助金额:$1.51万
-
财政年份:2007
-
负责人:ALLAN RAMIREZ
-
依托单位:
国内基金
海外基金
登录
查看更多内容
tRF-1:32-Glu-TTC-2-M2通过Smad3参与特发性肺动脉高压右心纤维化的机制研究
-
批准号:2026JJ81725
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:唐毅
-
依托单位:
基于上皮-间充质可塑性特征构建胶质瘤预后模型及靶向特定蛋白PTGFRN促进TGF-β/Smad3信号的机制研究
-
批准号:JCZRLH202601800
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
丁酸通过抑制HDAT6/TGF-β/Smad3介导的M2巨噬细胞极化改善慢性肾病肾纤维化
-
批准号:2026JJ82193
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖洁
-
依托单位:
益气解毒颗粒通过TGF-β1/Smad3信号通路调控巨噬细胞-肌成纤维细胞转化抑制鼻咽癌转移的机制研究
-
批准号:2026JJ81078
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:范婧莹
-
依托单位:
S100A4靶向TGF-β1/Smad3轴调控基底干细胞分化在Eos-CRSwNP病理中的作用
-
批准号:2025JJ81097
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邹上初
-
依托单位:
补肾强筋胶囊上调FTO介导SMAD3去甲基
化抑制软骨细胞肥大分化促进膝骨关节
炎软骨退变修复的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:曾明珠
-
依托单位:
5-ALA-PDT在治疗阴道上皮内瘤变过程中通过抑制TGF-β1/Smad3信号通路改善阴道壁弹性的机制研究
-
批准号:2025JJ70645
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张瑛
-
依托单位:
基于Smad3调控铁死亡和炎症反应探讨SARS-CoV-2N蛋白诱发糖尿病基础上急性肾损伤的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:梁莉莹
-
依托单位:
清金通络汤通过抑制 SIRT3/SMAD3 介导的巨噬细胞-肌
成纤维细胞转化( MMT )治疗IPF 的研究
-
批准号:2024JJ6359
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吴趋荟
-
依托单位:
M1型肿瘤相关巨噬细胞中SMAD3蛋白乳酸化修饰抑制其肿瘤抗原提呈的功能及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位: